KORU Medical Systems, Inc. (KRMD)Healthcare | Medical Instruments & Supplies | Mahwah, United States | NasdaqCM
3.00 USD
+0.03
(1.010%)
⇧
(Oct. 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 4:35 a.m. EDT
The investment case here is a classic tale of a turnaround story with a massive valuation gap. Fundamentally, the business is showing signs of life with 18% revenue growth and a return to positive adjusted EBITDA, supported by a healthy balance sheet and low debt. However, the market has priced in perfection, resulting in a forward P/E of 84x on expected earnings of just 3.5 cents. This leaves the stock vulnerable to any minor miss in execution. The short-term outlook is neutral to slightly cautious. While the stock recently rallied 34%, it is still trading well below its 200-day average, indicating lingering selling pressure. The statistical forecast model offers almost no guidance, predicting a negligible 0.03% move with low confidence, which suggests the price is currently stuck in a consolidation phase waiting for a catalyst. Long-term, I rate this a 3-star hold/buy. The trajectory over the last nine years has been spectacular, with nearly 900% cumulative gains driven by a successful pivot from a struggling legacy business to a high-growth medical device platform. The recent earnings beat confirms the new strategy is working. However, the lack of a dividend and the extreme valuation multiple mean this is not a defensive play. It requires patience and tolerance for volatility as the company scales. The options market is quietly betting on a significant upside move by early 2027, which aligns with the potential for the new product portfolio to fully mature. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.142589 |
| MSTL | 0.142950 |
| AutoTheta | 0.149255 |
| AutoARIMA | 0.188098 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 37% |
| H-stat | 3.52 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.001 |
| Excess Kurtosis | 0.37 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 18.333 |
| Revenue per Share | 0.975 |
| Market Cap | 138,515,712 |
| Forward P/E | 85.71 |
| Beta | 0.39 |
| Profit Margins | -4.03% |
| Previous Name | Repro Med Systems, Inc. |
| Website | https://www.korumedical.com |
As of Oct. 10, 2026, 4:35 a.m. EDT: Speculator positioning is extremely thin and fragmented. There is virtually no open interest in October or November expirations, suggesting a lack of immediate directional bets. In February 2027, there is a distinct concentration of out-of-the-money call open interest at the $5.0 strike, which sits significantly above the current price. This indicates a speculative thesis that the stock could double within the next 18 months, though the volume is low enough to suggest this is a niche trade rather than a broad consensus.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.27205884 |
| Address1 | 100 Corporate Drive |
| All Time High | 12.84 |
| All Time Low | 0.015 |
| Ask | 3.76 |
| Ask Size | 2 |
| Audit Risk | 6 |
| Average Daily Volume10 Day | 211,060 |
| Average Daily Volume3 Month | 239,826 |
| Average Volume | 239,826 |
| Average Volume10Days | 211,060 |
| Beta | 0.386 |
| Bid | 2.16 |
| Bid Size | 2 |
| Board Risk | 2 |
| Book Value | 0.391 |
| City | Mahwah |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 6 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.0 |
| Current Ratio | 2.718 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 3.04 |
| Day Low | 2.9285 |
| Debt To Equity | 18.333 |
| Display Name | KORU Medical Systems |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,785,961,800 |
| Earnings Call Timestamp Start | 1,785,961,800 |
| Earnings Timestamp | 1,785,960,000 |
| Earnings Timestamp End | 1,794,427,200 |
| Earnings Timestamp Start | 1,794,427,200 |
| Ebitda | -979,396 |
| Ebitda Margins | -0.021710001 |
| Enterprise To Ebitda | -136.347 |
| Enterprise To Revenue | 2.96 |
| Enterprise Value | 133,537,440 |
| Eps Current Year | -0.005 |
| Eps Forward | 0.035 |
| Eps Trailing Twelve Months | -0.04 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 845 469 5518 |
| Fifty Day Average | 3.2656 |
| Fifty Day Average Change | -0.26559997 |
| Fifty Day Average Change Percent | -0.08133267 |
| Fifty Two Week Change Percent | -27.205885 |
| Fifty Two Week High | 6.608 |
| Fifty Two Week High Change | -3.6079998 |
| Fifty Two Week High Change Percent | -0.54600483 |
| Fifty Two Week Low | 2.86 |
| Fifty Two Week Low Change | 0.1400001 |
| Fifty Two Week Low Change Percent | 0.048951086 |
| Fifty Two Week Range | 2.86 - 6.608 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 765,552,600,000 |
| Float Shares | 34,414,227 |
| Forward Eps | 0.035 |
| Forward P E | 85.71429 |
| Free Cashflow | 725,833 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 73 |
| Fullday Change | -0.06999993 |
| Fullday Change Percent | -2.3569 |
| Fullday Price | 3.0 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.62428004 |
| Gross Profits | 28,159,572 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.08214 |
| Held Percent Institutions | 0.56457 |
| Implied Shares Outstanding | 46,171,902 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey. |
| Long Name | KORU Medical Systems, Inc. |
| Market | us_market |
| Market Cap | 138,515,712 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_299866 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-10-14 |
| Net Income To Common | -1,819,451 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 150,982,119 |
| Number Of Analyst Opinions | 4 |
| Open | 2.95 |
| Operating Cashflow | 1,390,988 |
| Operating Margins | 0.05205 |
| Overall Risk | 1 |
| Payout Ratio | 0.0 |
| Phone | 845 469 2042 |
| Prev Name | Repro Med Systems, Inc. |
| Previous Close | 2.97 |
| Price Eps Current Year | -600.0 |
| Price Hint | 4 |
| Price To Book | 7.672634 |
| Price To Sales Trailing12 Months | 3.0707886 |
| Profit Margins | -0.04034 |
| Quick Ratio | 2.003 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.03 |
| Regular Market Change Percent | 1.0101 |
| Regular Market Day High | 3.04 |
| Regular Market Day Low | 2.9285 |
| Regular Market Day Range | 2.9285 - 3.04 |
| Regular Market Open | 2.95 |
| Regular Market Previous Close | 2.97 |
| Regular Market Price | 3.0 |
| Regular Market Time | 1,791,921,601 |
| Regular Market Volume | 318,016 |
| Return On Assets | -0.038629998 |
| Return On Equity | -0.10524 |
| Revenue Growth | 0.182 |
| Revenue Per Share | 0.975 |
| Sand P52 Week Change | 0.17502642 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 1 |
| Shares Outstanding | 46,171,902 |
| Shares Percent Shares Out | 0.0197 |
| Shares Short | 907,388 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 884,493 |
| Short Name | KORU Medical Systems, Inc. |
| Short Percent Of Float | 0.024 |
| Short Ratio | 3.4 |
| Source Interval | 15 |
| State | NJ |
| Symbol | KRMD |
| Target High Price | 8.0 |
| Target Low Price | 5.0 |
| Target Mean Price | 6.25 |
| Target Median Price | 6.0 |
| Total Cash | 8,287,704 |
| Total Cash Per Share | 0.179 |
| Total Debt | 3,309,439 |
| Total Revenue | 45,107,536 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.04 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 4.2096 |
| Two Hundred Day Average Change | -1.2096 |
| Two Hundred Day Average Change Percent | -0.2873432 |
| Type Disp | Equity |
| Volume | 318,016 |
| Website | https://www.korumedical.com |
| Zip | 7,430 |